Ligand Pharmaceuticals, Inc. (LGND)
232.23
+8.99
(+4.03%)
USD |
NASDAQ |
Apr 17, 16:00
231.97
-0.26
(-0.11%)
After-Hours: 20:00
Ligand Pharmaceuticals SG&A Expense (Quarterly) : 25.03M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 117.08M |
| Johnson & Johnson | 0.00 |
| ADMA Biologics, Inc. | 24.64M |
| Intuitive Surgical, Inc. | 687.10M |
| Establishment Labs Holdings, Inc. | 44.03M |